Black Barley Study - Barley to Support Food and Drink Innovation (RI-B7-3)
NCT ID: NCT06673212
Last Updated: 2024-11-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
11 participants
INTERVENTIONAL
2022-07-27
2024-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Effects of a Buckwheat Beverage on Postprandial Glucose Metabolism on Healthy and T2D Individuals
NCT03923205
Effects of Barley on Glucose Control
NCT02367989
A Single Supplement of a Standardised Bilberry Extract Modifies Glycaemic Response
NCT01245270
High-amylose Barley (HIAMBA) in the Regulation and Prevention of Type 2 Diabetes
NCT04702672
The Clinical Study of the Effect of Highland Barley Diet on Blood Glucose in Patients With Type 2 Diabetes Mellitus
NCT03766308
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Current research is exploring the potential of specifically bred food barleys to require less inputs in terms of nutrients and pesticides and grow on more marginal lands providing farmers with a crop harvested at a different time of year, mitigating against unpredictable weather and a changing climate. It is important that these barleys also deliver benefits to human health. There are established health claims with regard to the lipid lowering effect of (1,3;1,4)-β-glucan and phytochemical-rich barleys could also potentially reduce blood glucose, an important factor leading to metabolic deregulation and subsequent disease development. This would meet the needs of people choosing a healthy lifestyle, as well as those living with or at risk of T2DM. From the food collections being developed at the James Hutton Institute, an accession (high in (1,3;1,4)-β-glucan and phytochemicals) will be selected and tested in an acute dietary intervention to determine if postprandial blood glucose levels are reduced. This will be compared to control barley and wheat products.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Wheat Bread
Control Wheat Bread will be prepared to the same formulation as white wheat bread.
Control Wheat Bread
Ingredients: Wheat Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Berneray Bere barley bread
Berneray Bere barley bread will be prepared to a formulation as for the white wheat bread, but the wheat flour will be replaced with Berneray Bere barley flour.
Berneray Bere barley bread
Ingredients: Berneray Bere Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Black Barley bread
Black Barley bread will be prepared to a formulation as for the white wheat bread, but the wheat flour will be replaced with Black Barley flour.
Black Barley bread
Ingredients: Black Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Control Wheat Bread
Ingredients: Wheat Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Berneray Bere barley bread
Ingredients: Berneray Bere Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Black Barley bread
Ingredients: Black Barley Flour, Salt, Water, Allinson's Dried Active Yeast, Sugar
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Type 2 diabetes controlled with medication
* Coeliac Disease
* Eating disorders (anorexia, bulimia, binge eating or night eating syndrome)
* Food allergies/intolerances
* Any significant health issues
* Breastfeeding/ Pregnancy
* Addiction to any substances
* Are unable to give written informed consent
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Aberdeen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wendy Russell
Role: PRINCIPAL_INVESTIGATOR
University of Aberdeen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Aberdeen, The Rowett Institute
Aberdeen, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ROW_2022_001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.